HIV-1

Zhang J, Murray J, Mu W, Venugopal S, Yim E, Einhaus T, Radtke S, Peterson CW, Kiem HP, An DS. Evaluation of Anti-HIV-1 HSPC-Based Gene[...]

By afschroeder • October 28, 2026

Murphy CC, May FP, Kupfer SS, Hu X, Gupta S. Colorectal Cancer among U.S. Adults, 2000-2023. NEJM Evid. 2026 Nov;5(11):EVIDpha2600217. doi: 10.1056/EVIDpha2600217. Epub 2026 Oct[...]

By afschroeder • October 28, 2026

Wang Y, Arumugam B, Doud E, DeLuca D, Rebelo M, Yang OO, Spokoyny AM. Atomically Precise Polyanionic Boron Cluster Agents with Broad-Spectrum Antiviral Activity. Precis[...]

By afschroeder • June 2, 2026

Sun J, Nidadavolu LS, Hsu HY, Rajagopal RG, Astemborski J, Wu Y, Jiang Y, Sacha JB, Kievit P, Jamieson BD, Roberts CT, Kirk GD, Brown[...]

By afschroeder • January 21, 2026

Hsue PY, Behrens GMN, Xu ZJ, Zhao Y, Cmar J, Lahoulou R, Campo RE, Plank RM. Cardiovascular Risk Assessment Using the Atherosclerotic Cardiovascular Disease (ASCVD)[...]

By afschroeder • October 14, 2025

Guo Q, Parikh K, Zhang J, Brinkley A, Chen G, Jakramonpreeya N, Zhen A, An DS. Anti-HIV-1 HSPC-based gene therapy with safety kill switch to[...]

By sjmartinez • June 13, 2025

Daar ES, Orkin C, Sax PE, Hagins D, Pozniak A, Workowski K, Brinson C, Tiraboschi JM, Liu H, Deaton C, Cohen C, Madera S, Hindman[...]

By sjmartinez • April 9, 2025

Aziz N, LaBelle E, Jamieson BD, Mimiaga MJ, Detels R. Comparison of basic lymphocyte phenotype results between a diagnostic and a research laboratory. Lab Med.[...]

By sjmartinez • November 22, 2024

Murphy RA, Bedesi PH, Perumal N, Gosnell BI, Hatlen TJ, Brijkumar J. Dolutegravir Resistance in African Programmatic Settings Among Patients With Failure of Dolutegravir-based ART.[...]

By sjmartinez • July 1, 2024

Dimapasoc M, Moran JA, Cole SW, Ranjan A, Hourani R, Kim JT, Wender PA, Marsden MD, Zack JA. Defining the Effects of PKC Modulator HIV[...]

By sjmartinez • May 20, 2024